Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Its been such a good run of news. Which would move almost any biotech. Not to mention the extra pump we got from Zacks and other analyst. We will have our day before to long. There is no way this company is worth under 150 million.
I bet we close right on or below the 200 day line. This is one of the toughest stocks to track I have seen.
Great news. As long as results are as good previous trials we are perfect. Anything better is icing on the cake.
About to retest that .63. Hopefully we can get some volume support to break through it again.
With data this week, this looks like the makings of a short squeeze.
Good point. I was referring to the 5 milestones ONCS stated they would hit EOY. This looks to be an additional bit of news.
Hopefully this afternoon! Was this even a milestone?
Guys scoot over, we need to make some more room on this bandwagon. It is starting to get full.
2 million volume and no movement. Definition of accumulation. I think we are a few weeks from our big run. What do you think?
Look like we will need north of 4 million shares to break into .65. Big walls above us.
Ive never seen an official SEC filing so vague. We already have an S-3, and those shares should be registered. If issued would have to tell us how many.
Last post of the day. Just slapped the ask with 5gs. We should have all otc traders attention on technical's alone. Also if you had the balls to buy in the 30's and hold when everyone was screaming and running you just doubled your money. GLTA.
Volume popped back up as soon as the SA article hit. Maybe it will give it some juice.
I think today's price action made it clear that we will run when the MM's allow it. Probably on a day with no news. It will happen, the timing is anyone's guess though.
That was so criminal. It was such a concerted effort to keep this from moving up. It was an endless wall of shares on the ask. 1.5 million in 2 hours between. .57-.59 should have pushed us pass.
I think 1 million of it was between .58-.593. I'm not sure what it will take to get through that, but if we do the break out will be awesome.
I'm thinking the same thing. If we break .60 I'm throwing more cash at this.
If we make it through both where do you see the next resistance?
If we can get another million+ on the buy side over the next hour or two we might blow through it for a full break out.
We will know more at .60. If we blow through that we will set up for new highs and higher lows. If we are going to see selling it will be between .59 and .60. Its going to be interesting.
Hopefully they don't dump at .60 to keep it below resistance.
Zacks put out in article about another biotech im in last week with a much higher market cap. It was up 7.5% that day and 4% the next.
We still seem to be on a short leash by the MM's.
I hope the price action yesterday was from heavy shorting. This will be fun to watch.
I wonder if they will give us financials before the next quarterly.
It is good news, but not even in the top 2 best case scenarios. Merck is dipping their toe in the water instead of jumping in. Which is better than nothing but with Dr. Pierce on staff a little more support would have been nice. Also, ONCS does not have the money to run this trial with no extra cash and a trial for a new indication. They have shown before that they like to keep at least 12 months of operating cash on hand, so I expect to see the other 2/3 of the s-3 used in the near future.
Seems to be a lot of people on this board that should be invested in large caps or mutual funds. Know your risk tolerance. Also, I think this is great price action on good volume. Shares are being accumulated and we should run before too long. I will be looking to add over the next week.
Any ideas why this research is stand alone?
I think otc mm's are very aware of fundamental news. They buy and sell their inventory based on their expectations. They would get caught with their pants down if they were oblivious to high volume events.
Looks to be a 10 billion market cap company.
MM's could have bought shares for their own inventory expecting news, and are selling out of that today. It would explain the move up and remaining flat on the news with high volume.
Good volume. Should see a leg up.
I wish the PR was more detailed.
Its based on mouse trials and has no pd-1. Also does not discuss endpoints. So hopefully it is not.
Hopefully this is a side project to the p2b.
This must have been the PR we were waiting for!
I would think we would bottom out where we did a couple of months ago. and sit in the .40s. We should have good data and a new trial would still be positive, but the lack of validation would hurt the pps.
If ONCS were to obtain a partner and begin a new indication IMO INO in the summer of 2013, with a market cap of 500 million after their run, would be a good parallel for ONCS over the next few months.
Clearly "90% of statistics are made up" is made up. Saying that you know things to a 90% certainty that are internal to the company, with no possible way of knowing to any significant degree is misleading. This board is a wealth of information, and we should keep it as accurate as possible. As the PPS rises we will have more investors looking to this board for information.
90% of statistics are made up. Don't guess at things and make them sound like fact.